These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7773242)

  • 1. Potential animal models of Helicobacter pylori infection in immunological and vaccine research.
    Engstrand L
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):265-70. PubMed ID: 7773242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
    Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
    Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
    Harbour SN; Mitchell HM; Sutton P
    Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence of Helicobacter pylori to the gastric mucosa.
    Clyne M; Drumm B
    Can J Gastroenterol; 1997 Apr; 11(3):243-8. PubMed ID: 9167032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.
    McGuckin MA; Every AL; Skene CD; Linden SK; Chionh YT; Swierczak A; McAuley J; Harbour S; Kaparakis M; Ferrero R; Sutton P
    Gastroenterology; 2007 Oct; 133(4):1210-8. PubMed ID: 17919495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a vaccine against Helicobacter pylori infection.
    Michetti P
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S339-41. PubMed ID: 10077770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in vaccination against Helicobacter pylori.
    Velin D; Michetti P
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination.
    Prinz C; Hafsi N; Voland P
    Trends Microbiol; 2003 Mar; 11(3):134-8. PubMed ID: 12648945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of Helicobacter pylori infection and disease.
    O'Rourke JL; Lee A
    Microbes Infect; 2003 Jul; 5(8):741-8. PubMed ID: 12814775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental model of Helicobacter pylori infection.
    Del Giudice G; Ghiara P; Rappuoli R
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S261-3. PubMed ID: 10077750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
    Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
    Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
    J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
    Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
    Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of vaccine research and development for Helicobacter pylori.
    Sutton P; Boag JM
    Vaccine; 2019 Nov; 37(50):7295-7299. PubMed ID: 29627231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
    Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current progress in the development of prophylactic and therapeutic vaccination against H. pylori infection].
    Nishizono A
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():745-50. PubMed ID: 11979882
    [No Abstract]   [Full Text] [Related]  

  • 20. Helicobacter pylori vaccine development: facing the challenge.
    Aebischer T; Schmitt A; Walduck AK; Meyer TF
    Int J Med Microbiol; 2005 Sep; 295(5):343-53. PubMed ID: 16173501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.